Health

The Global and China L4 Autonomous Driving and Start-ups Report, 2021, found that except for a few companies, such as Waymo and Uber, which performed worse than expected, level four (L4) autonomous driving firms in other fields gained momentum.

Hikma led a $15m extension to surgical robotics developer Activ Surgical's series B round, now sized at $60m, while data collaboration software provider Hex raised $52m from investors including Snowflake and Databricks.

Leaps by Bayer co-led an oversubscribed round for the oncology therapeutics developer, with the proceeds to go to clinical trials and supplementary licences.

Deutsche Telekom-backed DTCP was among the investors that pushed the cybersecurity management platform developer’s valuation to $2.6bn.

Artificial intelligence technology developer Aibee raised cash from Xiaomi at a unicorn valuation while industrial technology provider Bluetron received $78.6m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.

Bayer's impact investment arm returned for the round's $45m second close, as Triumvera looks to progess its solid tumour therapeutic candidate.

With a remit across healthcare, life sciences and advanced materials, Merck’s corporate venturing unit is scoping an opportunity-filled landscape.

Radiopharmaceuticals developer Precirix completed an $88m series B round featuring Novo while corporate-backed kitchen technology provider Bear Robotics raised $81m.

UGent, VUB, UAntwerpen, UHasselt, ULiège, VITO and Imec are all among the partners of Qbic, which has raised $54m for its third fund.